发明名称 |
METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1 |
摘要 |
A method for preventing or reducing adverse effects such as profuse sweating, nausea and vomiting, which normally are associated with subcutaneous and intravenous administration of glucagon-like peptide 1 (GLP-1) therapy is provided. In particular, the method comprises the rapid administration of a GLP-1 formulation into the pulmonary circulation such as by inhalation, directly into pulmonary alveolar capillaries using a dry powder drug delivery system.
|
申请公布号 |
US2009110647(A1) |
申请公布日期 |
2009.04.30 |
申请号 |
US20080258340 |
申请日期 |
2008.10.24 |
申请人 |
RICHARDSON PETER;BAUGHMAN ROBERT A;COSTELLO DONALD |
发明人 |
RICHARDSON PETER;BAUGHMAN ROBERT A.;COSTELLO DONALD |
分类号 |
A61K9/14;A61K38/00;A61K38/28;A61P3/10 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|